REFERENCES
- Brumfitt W, Hamilton-Miller JMT. Reassessment of the rationale for the combinations of sulphonamides with diaminopyrimidines. J Chemother 1993; 5: 465–469.
- Csonka GW, Knight GJ. Therapeutic trial of trimetho-prim as a potentiator of sulphonamides in gonorrhoea. Br J Vener Dis 1967; 43: 161–165.
- Medina I, Mills J, Leoung G, et al. Oral therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. New Engl J Med 1990; 323: 776–782.
- Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS and Klein JC eds. Infectious diseases of the fetus and the newborn infant, 3rd ed. Philadelphia: Saunders, 1990.
- Hutchison DBA, Farquhar JA. Trimethoprim-sul-famethoxazole in the treatment of malaria, toxoplasmosis, and pediculosis. Rev Infec Dis 1982; 4: 419–425.
- Joint FAO/WHO Expert Committee on Brucellosis. Geneva: World Health Organization, 1986.
- Ariza J, Gudiol F, Pallares R, Rufi G, Fernandez-Viladrich P. Comparative trial of co-trimoxazole versus tetra-cycline- streptomycin in treating human brucellosis. J Infect Dis 1985; 152: 1358.
- Lerner DI. Nocardia species. In: Mandell GL, Douglas RG and Bennett JE eds Principles and practice of infectious diseases, 3rd ed. New York & Edinburgh: Churchill-Livingstone, 1990: 1926–1932.
- Cockerill FR, Edson RS. Trimethoprim-sulfamethoxa-zole. Mayo Clin Proc 1991; 66: 1260–1269.